KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Operating Leases: 2019-2024

Historic Operating Leases for Dynavax Technologies (DVAX) over the last 6 years, with Dec 2024 value amounting to $30.6 million.

  • Dynavax Technologies' Operating Leases fell 9.17% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 million, marking a year-over-year decrease of 9.17%. This contributed to the annual value of $30.6 million for FY2024, which is 10.68% down from last year.
  • Latest data reveals that Dynavax Technologies reported Operating Leases of $30.6 million as of FY2024, which was down 10.68% from $34.2 million recorded in FY2023.
  • Over the past 5 years, Dynavax Technologies' Operating Leases peaked at $34.8 million during FY2020, and registered a low of $30.6 million during FY2024.
  • Over the past 3 years, Dynavax Technologies' median Operating Leases value was $32.8 million (recorded in 2022), while the average stood at $32.5 million.
  • Per our database at Business Quant, Dynavax Technologies' Operating Leases grew by 4.31% in 2023 and then fell by 10.68% in 2024.
  • Yearly analysis of 5 years shows Dynavax Technologies' Operating Leases stood at $34.8 million in 2020, then decreased by 1.36% to $34.3 million in 2021, then decreased by 4.41% to $32.8 million in 2022, then increased by 4.31% to $34.2 million in 2023, then declined by 10.68% to $30.6 million in 2024.